Evidence map›Paper›PMID 18622013›Full record

ArticleThe Journal of biological chemistry2008

Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Prasad Rallabhandi, Quan M Nhu, Vladimir Y Toshchakov, Wenji Piao, Andrei E Medvedev, Morley D Hollenberg, Alessio Fasano, Stefanie N Vogel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Diversification of PAR signaling through receptor crosstalk.Cellular & molecular biology letters · 2022
    Review
  17. Article
  18. Protease-activated receptor 2 enhances innate and inflammatory mechanisms induced by lipopolysaccharide in macrophages from C57BL/6 mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  19. Article
  20. International journal of molecular sciences · 2021
    Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Prasad RallabhandiDepartment of Microbiology and Immunology, University of Maryland, Baltimore, Maryland 21201, USA.
Quan M Nhu
Vladimir Y Toshchakov
Wenji Piao
Andrei E Medvedev
Morley D Hollenberg
Alessio Fasano
Stefanie N Vogel
University of Maryland, Baltimore · USUniversity of Calgary · CA

Funding

DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATIONR37AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2000 to 2009
$5.3M
Zot, Zonulin, and Pathophysiology of Intestinal Tight JunctionsR01DK048373 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI FASANO, ALESSIO · 1996 to 2015
$4.4M
Effect of Bacterial Tolerance on TLR Signal TransductionR01AI059524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI MEDVEDEV, ANDREI E · 2005 to 2014
$2.6M
IMMUNITY AND INFECTIONT32AI007540 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 1998 to 2018
$2.2M
NIAID NIH HHS R01 AI-059524NIAID NIH HHS R01 AI059524NIAID NIH HHS R37 AI018797NIAID NIH HHS R37 AI-18797NIAID NIH HHS T32 AI007540NIAID NIH HHS T32 AI-07540NIDDK NIH HHS R01 DK048373
6 · The paper itself

Abstract

Proteinase-activated receptor 2 (PAR2), a seven-transmembrane G protein-coupled receptor, is activated at inflammatory sites by proteolytic cleavage of its extracellular N terminus by trypsin-like enzymes, exposing a tethered, receptor-activating ligand. Synthetic agonist peptides (AP) that share the tethered ligand sequence also activate PAR2, often measured by Ca2+ release. PAR2 contributes to inflammation through activation of NF-kappaB-regulated genes; however, the mechanism by which this occurs is unknown. Overexpression of human PAR2 in HEK293T cells resulted in concentration-dependent, PAR2 AP-inducible NF-kappaB reporter activation that was protein synthesis-independent, yet blocked by inhibitors that uncouple Gi proteins or sequester intracellular Ca2+. Because previous studies described synergistic PAR2- and TLR4-mediated cytokine production, we hypothesized that PAR2 and TLR4 might interact at the level of signaling. In the absence of TLR4, PAR2-induced NF-kappaB activity was inhibited by dominant negative (DN)-TRIF or DN-TRAM constructs, but not by DN-MyD88, findings confirmed using cell-permeable, adapter-specific BB loop blocking peptides. Co-expression of TLR4/MD-2/CD14 with PAR2 in HEK293T cells led to a synergistic increase in AP-induced NF-kappaB signaling that was MyD88-dependent and required a functional TLR4, despite the fact that AP exhibited no TLR4 agonist activity. Co-immunoprecipitation of PAR2 and TLR4 revealed a physical association that was AP-dependent. The response to AP or lipopolysaccharide was significantly diminished in TLR4(-/-) and PAR2(-/-) macrophages, respectively, and SW620 colonic epithelial cells exhibited synergistic responses to co-stimulation with AP and lipopolysaccharide. Our data suggest a unique interaction between two distinct innate immune response receptors and support a novel paradigm of receptor cooperativity in inflammatory responses.

Indexed as

Immunity, InnateAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAnimalsCell LineCytokinesGenes, DominantHumansInflammationLipopolysaccharidesMacrophages, PeritonealMiceMice, KnockoutMyeloid Differentiation Factor 88NF-kappa BOligopeptidesAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportCytokinesLipopolysaccharidesMYD88 protein, humanMyd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BOligopeptidesReceptor, PAR-2Receptors, InterleukinTICAM1 protein, humanTicam1 protein, mouseTICAM2 protein, humanTicam2 protein, mouseTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID18622013
PMCPMC2528983
OpenAlexW2057552543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.